| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 38 | 2026 | 1377 | 2.910 |
Why?
|
| Health Knowledge, Attitudes, Practice | 35 | 2025 | 770 | 2.370 |
Why?
|
| Health Surveys | 28 | 2026 | 319 | 1.790 |
Why?
|
| Neurosurgery | 6 | 2025 | 31 | 1.730 |
Why?
|
| Internet | 14 | 2025 | 472 | 1.350 |
Why?
|
| Neurosurgical Procedures | 3 | 2025 | 105 | 1.290 |
Why?
|
| United States | 81 | 2026 | 8190 | 1.200 |
Why?
|
| Health Behavior | 20 | 2026 | 485 | 1.180 |
Why?
|
| Adult | 104 | 2026 | 17567 | 1.140 |
Why?
|
| Humans | 189 | 2026 | 65826 | 1.030 |
Why?
|
| Adolescent | 65 | 2026 | 6367 | 1.000 |
Why?
|
| Young Adult | 44 | 2026 | 4878 | 0.990 |
Why?
|
| Cooperative Behavior | 10 | 2012 | 230 | 0.990 |
Why?
|
| Information Seeking Behavior | 9 | 2025 | 39 | 0.990 |
Why?
|
| Attitude to Death | 3 | 2013 | 19 | 0.950 |
Why?
|
| Middle Aged | 84 | 2026 | 18491 | 0.940 |
Why?
|
| Health Care Surveys | 10 | 2022 | 289 | 0.930 |
Why?
|
| Neurosurgeons | 1 | 2025 | 8 | 0.930 |
Why?
|
| Patient-Centered Care | 4 | 2022 | 268 | 0.910 |
Why?
|
| Surveys and Questionnaires | 33 | 2025 | 2790 | 0.890 |
Why?
|
| Communication | 7 | 2022 | 608 | 0.880 |
Why?
|
| Male | 111 | 2026 | 31398 | 0.870 |
Why?
|
| Vegetables | 9 | 2015 | 67 | 0.860 |
Why?
|
| Bone Neoplasms | 16 | 1994 | 124 | 0.860 |
Why?
|
| Fruit | 9 | 2015 | 103 | 0.850 |
Why?
|
| Female | 112 | 2026 | 34414 | 0.830 |
Why?
|
| Retirement | 1 | 2024 | 21 | 0.830 |
Why?
|
| Health Services Accessibility | 10 | 2025 | 603 | 0.800 |
Why?
|
| Athletes | 1 | 2024 | 109 | 0.750 |
Why?
|
| Quality of Life | 8 | 2025 | 1267 | 0.740 |
Why?
|
| National Cancer Institute (U.S.) | 13 | 2025 | 37 | 0.720 |
Why?
|
| Physician-Patient Relations | 4 | 2021 | 429 | 0.720 |
Why?
|
| Attitude to Health | 9 | 2013 | 296 | 0.690 |
Why?
|
| Sexual and Gender Minorities | 2 | 2020 | 76 | 0.670 |
Why?
|
| Cross-Sectional Studies | 26 | 2026 | 2737 | 0.670 |
Why?
|
| Patient Acceptance of Health Care | 7 | 2013 | 505 | 0.650 |
Why?
|
| Public Opinion | 1 | 2020 | 26 | 0.650 |
Why?
|
| Information Services | 5 | 2016 | 35 | 0.640 |
Why?
|
| Aged | 60 | 2026 | 15141 | 0.630 |
Why?
|
| Alcohol Drinking | 6 | 2026 | 325 | 0.630 |
Why?
|
| Interdisciplinary Communication | 6 | 2012 | 106 | 0.610 |
Why?
|
| Religion and Medicine | 2 | 2019 | 20 | 0.590 |
Why?
|
| Emigrants and Immigrants | 1 | 2020 | 47 | 0.590 |
Why?
|
| Perception | 5 | 2020 | 187 | 0.580 |
Why?
|
| Papillomaviridae | 1 | 2019 | 59 | 0.570 |
Why?
|
| Prostatic Neoplasms | 4 | 2020 | 502 | 0.560 |
Why?
|
| Smoking | 12 | 2016 | 864 | 0.550 |
Why?
|
| Breast Neoplasms | 6 | 2015 | 1235 | 0.550 |
Why?
|
| Group Processes | 5 | 2008 | 42 | 0.550 |
Why?
|
| Patient Participation | 1 | 2020 | 239 | 0.540 |
Why?
|
| Mass Screening | 8 | 2020 | 700 | 0.540 |
Why?
|
| Papillomavirus Vaccines | 1 | 2019 | 69 | 0.530 |
Why?
|
| Brain Neoplasms | 5 | 2015 | 321 | 0.530 |
Why?
|
| Feeding Behavior | 5 | 2015 | 266 | 0.530 |
Why?
|
| Tobacco Use | 1 | 2018 | 42 | 0.530 |
Why?
|
| Papillomavirus Infections | 1 | 2019 | 134 | 0.510 |
Why?
|
| Schools | 5 | 2022 | 170 | 0.510 |
Why?
|
| Sunburn | 3 | 2026 | 14 | 0.500 |
Why?
|
| Sexual Behavior | 2 | 2018 | 192 | 0.490 |
Why?
|
| Research Personnel | 5 | 2008 | 82 | 0.480 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2015 | 155 | 0.460 |
Why?
|
| Consumer Health Information | 6 | 2025 | 41 | 0.460 |
Why?
|
| Healthy People Programs | 4 | 2020 | 11 | 0.460 |
Why?
|
| Abdominal Pain | 1 | 2016 | 99 | 0.460 |
Why?
|
| Medical Informatics | 6 | 2019 | 72 | 0.460 |
Why?
|
| Health Status | 7 | 2014 | 448 | 0.450 |
Why?
|
| Prostate-Specific Antigen | 2 | 2020 | 84 | 0.450 |
Why?
|
| Health Communication | 6 | 2019 | 33 | 0.440 |
Why?
|
| Heart Diseases | 2 | 2014 | 223 | 0.430 |
Why?
|
| Goals | 4 | 2020 | 96 | 0.430 |
Why?
|
| Weight Loss | 1 | 2016 | 276 | 0.410 |
Why?
|
| Socioeconomic Factors | 18 | 2017 | 806 | 0.400 |
Why?
|
| Soft Tissue Neoplasms | 9 | 1995 | 32 | 0.390 |
Why?
|
| Huntingtin Protein | 3 | 2019 | 151 | 0.390 |
Why?
|
| Research | 2 | 2012 | 195 | 0.380 |
Why?
|
| Prevalence | 8 | 2026 | 1453 | 0.370 |
Why?
|
| Early Detection of Cancer | 6 | 2020 | 327 | 0.370 |
Why?
|
| Acculturation | 4 | 2015 | 38 | 0.370 |
Why?
|
| Colorectal Neoplasms | 2 | 2015 | 290 | 0.370 |
Why?
|
| Age Factors | 12 | 2020 | 1595 | 0.370 |
Why?
|
| Motor Activity | 5 | 2014 | 347 | 0.370 |
Why?
|
| Biomedical Research | 4 | 2016 | 263 | 0.370 |
Why?
|
| Databases, Factual | 3 | 2016 | 888 | 0.360 |
Why?
|
| Diabetes Mellitus | 2 | 2014 | 556 | 0.350 |
Why?
|
| Diet | 8 | 2022 | 540 | 0.350 |
Why?
|
| Osteosarcoma | 6 | 1994 | 49 | 0.340 |
Why?
|
| Information Dissemination | 4 | 2016 | 114 | 0.340 |
Why?
|
| Genetic Therapy | 5 | 2025 | 852 | 0.340 |
Why?
|
| Sex Factors | 9 | 2018 | 995 | 0.330 |
Why?
|
| Magnetic Resonance Imaging | 22 | 2015 | 2324 | 0.320 |
Why?
|
| Cancer Survivors | 2 | 2024 | 130 | 0.320 |
Why?
|
| Nutrition Surveys | 8 | 2016 | 149 | 0.310 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2010 | 37 | 0.310 |
Why?
|
| Nutrition Policy | 4 | 2014 | 42 | 0.310 |
Why?
|
| Skin Neoplasms | 5 | 2026 | 411 | 0.300 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2010 | 65 | 0.300 |
Why?
|
| Patient Satisfaction | 6 | 2025 | 442 | 0.300 |
Why?
|
| Sunbathing | 2 | 2026 | 32 | 0.290 |
Why?
|
| Radiosurgery | 1 | 2010 | 69 | 0.290 |
Why?
|
| Neoplasms, Multiple Primary | 6 | 1993 | 33 | 0.290 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2008 | 23 | 0.290 |
Why?
|
| Logistic Models | 10 | 2022 | 1274 | 0.280 |
Why?
|
| Exercise | 7 | 2026 | 970 | 0.280 |
Why?
|
| Hypertension | 1 | 2014 | 618 | 0.270 |
Why?
|
| Diet Surveys | 5 | 2011 | 43 | 0.270 |
Why?
|
| User-Computer Interface | 1 | 2008 | 127 | 0.270 |
Why?
|
| Survivors | 3 | 2016 | 187 | 0.270 |
Why?
|
| Mass Media | 4 | 2013 | 34 | 0.270 |
Why?
|
| Psychometrics | 3 | 2025 | 396 | 0.270 |
Why?
|
| Food Preferences | 3 | 2013 | 52 | 0.270 |
Why?
|
| Cognition | 1 | 2012 | 514 | 0.260 |
Why?
|
| Electronic Health Records | 3 | 2017 | 398 | 0.260 |
Why?
|
| Global Health | 3 | 2024 | 181 | 0.260 |
Why?
|
| Trust | 4 | 2020 | 81 | 0.250 |
Why?
|
| Reproducibility of Results | 7 | 2025 | 1720 | 0.250 |
Why?
|
| Military Personnel | 2 | 2001 | 111 | 0.250 |
Why?
|
| Health Promotion | 7 | 2012 | 523 | 0.250 |
Why?
|
| Data Collection | 7 | 2020 | 384 | 0.250 |
Why?
|
| Ovarian Neoplasms | 2 | 2019 | 170 | 0.250 |
Why?
|
| Child | 19 | 2025 | 4653 | 0.240 |
Why?
|
| Meningeal Neoplasms | 3 | 2015 | 63 | 0.240 |
Why?
|
| Meningioma | 3 | 2015 | 65 | 0.240 |
Why?
|
| Multiple Chronic Conditions | 2 | 2017 | 40 | 0.240 |
Why?
|
| Latin America | 1 | 2025 | 17 | 0.230 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2025 | 8 | 0.230 |
Why?
|
| Neuroendoscopy | 1 | 2025 | 2 | 0.230 |
Why?
|
| Product Labeling | 1 | 2025 | 9 | 0.230 |
Why?
|
| Developing Countries | 3 | 2025 | 87 | 0.230 |
Why?
|
| Ultraviolet Rays | 1 | 2026 | 153 | 0.220 |
Why?
|
| Smoking Cessation | 3 | 2013 | 553 | 0.220 |
Why?
|
| Social Support | 4 | 2015 | 394 | 0.220 |
Why?
|
| Tomography, X-Ray Computed | 15 | 2016 | 1665 | 0.220 |
Why?
|
| Hydrocephalus | 1 | 2025 | 41 | 0.220 |
Why?
|
| Personal Satisfaction | 2 | 2024 | 83 | 0.220 |
Why?
|
| Delivery of Health Care | 4 | 2022 | 439 | 0.220 |
Why?
|
| Risk Factors | 14 | 2026 | 5471 | 0.220 |
Why?
|
| Thalamus | 1 | 2025 | 78 | 0.220 |
Why?
|
| Body Mass Index | 4 | 2017 | 901 | 0.210 |
Why?
|
| Vocabulary, Controlled | 2 | 2016 | 4 | 0.210 |
Why?
|
| Colonic Neoplasms | 4 | 2009 | 220 | 0.210 |
Why?
|
| Food Services | 2 | 2014 | 25 | 0.210 |
Why?
|
| Lung Neoplasms | 8 | 2013 | 712 | 0.200 |
Why?
|
| Micronutrients | 1 | 2024 | 20 | 0.200 |
Why?
|
| Educational Status | 7 | 2017 | 279 | 0.200 |
Why?
|
| Language | 1 | 2025 | 155 | 0.200 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 993 | 0.200 |
Why?
|
| Spinal Dysraphism | 1 | 2024 | 18 | 0.200 |
Why?
|
| Huntington Disease | 2 | 2018 | 164 | 0.200 |
Why?
|
| Professional-Patient Relations | 3 | 2016 | 128 | 0.200 |
Why?
|
| Pediatric Obesity | 2 | 2017 | 129 | 0.200 |
Why?
|
| Fanconi Anemia | 2 | 2013 | 15 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2025 | 736 | 0.200 |
Why?
|
| Bolivia | 3 | 2025 | 3 | 0.190 |
Why?
|
| Food Supply | 2 | 2015 | 58 | 0.190 |
Why?
|
| Diagnosis, Differential | 9 | 2016 | 995 | 0.190 |
Why?
|
| Family | 3 | 2013 | 250 | 0.190 |
Why?
|
| Sibling Relations | 1 | 2002 | 5 | 0.190 |
Why?
|
| Giant Cell Tumors | 3 | 1992 | 8 | 0.190 |
Why?
|
| Bias | 3 | 2022 | 117 | 0.190 |
Why?
|
| Pediatrics | 1 | 2025 | 265 | 0.190 |
Why?
|
| Factor Analysis, Statistical | 1 | 2022 | 103 | 0.190 |
Why?
|
| Physicians, Family | 3 | 1991 | 76 | 0.180 |
Why?
|
| Tibia | 4 | 1992 | 76 | 0.180 |
Why?
|
| Robotic Surgical Procedures | 1 | 2025 | 172 | 0.180 |
Why?
|
| Behavioral Research | 1 | 2022 | 15 | 0.180 |
Why?
|
| Parent-Child Relations | 1 | 2002 | 69 | 0.180 |
Why?
|
| Radiography | 12 | 2010 | 559 | 0.180 |
Why?
|
| Motivation | 1 | 2024 | 298 | 0.170 |
Why?
|
| Occupational Medicine | 2 | 1993 | 13 | 0.170 |
Why?
|
| Self Efficacy | 4 | 2016 | 206 | 0.170 |
Why?
|
| Beverages | 3 | 2017 | 70 | 0.170 |
Why?
|
| Guideline Adherence | 3 | 2014 | 310 | 0.170 |
Why?
|
| Bioterrorism | 1 | 2001 | 8 | 0.170 |
Why?
|
| Biological Warfare | 1 | 2001 | 4 | 0.170 |
Why?
|
| Neostriatum | 2 | 2018 | 26 | 0.170 |
Why?
|
| Parents | 3 | 2013 | 418 | 0.170 |
Why?
|
| Risk | 3 | 2017 | 375 | 0.170 |
Why?
|
| Tay-Sachs Disease | 1 | 2022 | 55 | 0.170 |
Why?
|
| Models, Organizational | 4 | 2008 | 93 | 0.170 |
Why?
|
| Science | 4 | 2008 | 34 | 0.170 |
Why?
|
| Glioblastoma | 3 | 2015 | 161 | 0.170 |
Why?
|
| Risk Assessment | 6 | 2015 | 2113 | 0.170 |
Why?
|
| National Institutes of Health (U.S.) | 4 | 2016 | 117 | 0.170 |
Why?
|
| Dacarbazine | 2 | 2010 | 18 | 0.160 |
Why?
|
| Disaster Planning | 1 | 2001 | 57 | 0.160 |
Why?
|
| Decision Making | 3 | 2013 | 430 | 0.160 |
Why?
|
| Health Records, Personal | 2 | 2017 | 26 | 0.160 |
Why?
|
| Dependovirus | 5 | 2022 | 760 | 0.160 |
Why?
|
| Self Report | 2 | 2014 | 395 | 0.160 |
Why?
|
| California | 4 | 2014 | 178 | 0.160 |
Why?
|
| Uncertainty | 2 | 2013 | 40 | 0.160 |
Why?
|
| Multivariate Analysis | 6 | 2017 | 932 | 0.150 |
Why?
|
| Salpingo-oophorectomy | 1 | 2019 | 5 | 0.150 |
Why?
|
| Consumer Behavior | 2 | 2010 | 38 | 0.150 |
Why?
|
| Telemedicine | 2 | 2020 | 379 | 0.150 |
Why?
|
| Hemangioma | 5 | 1994 | 27 | 0.150 |
Why?
|
| Students | 1 | 2022 | 227 | 0.150 |
Why?
|
| Registries | 4 | 2024 | 934 | 0.150 |
Why?
|
| Aged, 80 and over | 11 | 2019 | 5681 | 0.150 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 95 | 0.140 |
Why?
|
| Access to Information | 2 | 2016 | 31 | 0.140 |
Why?
|
| Fibroma | 4 | 1991 | 14 | 0.140 |
Why?
|
| Child, Preschool | 11 | 2025 | 2088 | 0.140 |
Why?
|
| Choice Behavior | 2 | 2017 | 86 | 0.140 |
Why?
|
| Muscular Diseases | 3 | 1994 | 51 | 0.140 |
Why?
|
| Quality of Health Care | 2 | 2015 | 535 | 0.140 |
Why?
|
| Genetic Vectors | 4 | 2025 | 929 | 0.140 |
Why?
|
| Caudate Nucleus | 1 | 2018 | 25 | 0.130 |
Why?
|
| Putamen | 1 | 2018 | 21 | 0.130 |
Why?
|
| Carbonated Beverages | 2 | 2017 | 21 | 0.130 |
Why?
|
| Femoral Neoplasms | 3 | 1992 | 5 | 0.130 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 133 | 0.130 |
Why?
|
| Obesity | 5 | 2014 | 1279 | 0.130 |
Why?
|
| Mutant Proteins | 1 | 2018 | 105 | 0.130 |
Why?
|
| Sweetening Agents | 1 | 2017 | 20 | 0.130 |
Why?
|
| Sheep | 4 | 2021 | 194 | 0.130 |
Why?
|
| Prophylactic Surgical Procedures | 1 | 2017 | 1 | 0.130 |
Why?
|
| Internationality | 1 | 2017 | 46 | 0.130 |
Why?
|
| Salpingectomy | 1 | 2017 | 5 | 0.130 |
Why?
|
| Anesthesia | 1 | 2017 | 52 | 0.130 |
Why?
|
| Central Nervous System | 1 | 2019 | 205 | 0.130 |
Why?
|
| Genes, BRCA2 | 1 | 2017 | 13 | 0.130 |
Why?
|
| Genes, BRCA1 | 1 | 2017 | 18 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 2 | 1992 | 354 | 0.130 |
Why?
|
| Virus Internalization | 1 | 2018 | 91 | 0.130 |
Why?
|
| Biomarkers | 2 | 2014 | 1502 | 0.130 |
Why?
|
| Ovariectomy | 1 | 2017 | 104 | 0.120 |
Why?
|
| Wireless Technology | 1 | 2016 | 14 | 0.120 |
Why?
|
| Survival Rate | 2 | 2016 | 847 | 0.120 |
Why?
|
| Medical Informatics Computing | 1 | 2016 | 1 | 0.120 |
Why?
|
| Patient Education as Topic | 2 | 2019 | 489 | 0.120 |
Why?
|
| Common Data Elements | 1 | 2016 | 5 | 0.120 |
Why?
|
| Life Style | 3 | 2014 | 324 | 0.120 |
Why?
|
| Health Education | 4 | 2013 | 191 | 0.120 |
Why?
|
| Odds Ratio | 7 | 2011 | 757 | 0.120 |
Why?
|
| Obstetrics | 1 | 2017 | 91 | 0.120 |
Why?
|
| Mental Health | 2 | 2025 | 364 | 0.120 |
Why?
|
| Surgical Procedures, Operative | 1 | 2017 | 145 | 0.120 |
Why?
|
| Hand Strength | 1 | 2016 | 34 | 0.120 |
Why?
|
| Smoking Prevention | 4 | 2013 | 163 | 0.120 |
Why?
|
| Physicians | 1 | 2021 | 486 | 0.120 |
Why?
|
| Urban Population | 1 | 2017 | 201 | 0.120 |
Why?
|
| Physical Fitness | 1 | 2016 | 93 | 0.120 |
Why?
|
| Contrast Media | 3 | 2015 | 435 | 0.110 |
Why?
|
| Caregivers | 2 | 2012 | 298 | 0.110 |
Why?
|
| Longitudinal Studies | 2 | 2018 | 1291 | 0.110 |
Why?
|
| Convection | 2 | 2013 | 10 | 0.110 |
Why?
|
| Chondrosarcoma | 2 | 1994 | 7 | 0.110 |
Why?
|
| Sunscreening Agents | 4 | 2026 | 22 | 0.110 |
Why?
|
| Demeclocycline | 1 | 2015 | 4 | 0.110 |
Why?
|
| Tobacco Use Disorder | 2 | 2008 | 248 | 0.110 |
Why?
|
| Neurons | 2 | 2018 | 935 | 0.110 |
Why?
|
| Accidents, Aviation | 1 | 1995 | 3 | 0.110 |
Why?
|
| Time Factors | 6 | 2013 | 3778 | 0.110 |
Why?
|
| Thigh | 7 | 1994 | 28 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2010 | 378 | 0.110 |
Why?
|
| Interviews as Topic | 6 | 2014 | 536 | 0.110 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 251 | 0.110 |
Why?
|
| Recommended Dietary Allowances | 1 | 2014 | 8 | 0.110 |
Why?
|
| Legislation, Food | 1 | 2014 | 3 | 0.110 |
Why?
|
| Public Health | 2 | 2014 | 188 | 0.110 |
Why?
|
| Osteoma, Osteoid | 2 | 1991 | 4 | 0.110 |
Why?
|
| Rural Population | 1 | 2017 | 225 | 0.110 |
Why?
|
| Ischium | 1 | 1994 | 2 | 0.110 |
Why?
|
| Chronic Disease | 2 | 2017 | 745 | 0.110 |
Why?
|
| Food Dispensers, Automatic | 2 | 2013 | 2 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 240 | 0.100 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 37 | 0.100 |
Why?
|
| Eating | 1 | 2015 | 140 | 0.100 |
Why?
|
| Resistance Training | 1 | 2014 | 22 | 0.100 |
Why?
|
| Computational Biology | 1 | 2016 | 369 | 0.100 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 348 | 0.100 |
Why?
|
| Taxes | 1 | 2013 | 6 | 0.100 |
Why?
|
| Primary Prevention | 2 | 2013 | 137 | 0.100 |
Why?
|
| Management Quality Circles | 1 | 1993 | 2 | 0.100 |
Why?
|
| Famous Persons | 1 | 2013 | 6 | 0.100 |
Why?
|
| Behavioral Sciences | 1 | 2013 | 2 | 0.100 |
Why?
|
| Accelerometry | 1 | 2014 | 64 | 0.100 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2014 | 65 | 0.100 |
Why?
|
| Anxiety | 3 | 2008 | 427 | 0.100 |
Why?
|
| Glioma | 2 | 2015 | 101 | 0.100 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2010 | 33 | 0.100 |
Why?
|
| Models, Economic | 1 | 2013 | 42 | 0.100 |
Why?
|
| Occupational Health Services | 1 | 1993 | 37 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 79 | 0.100 |
Why?
|
| Guidelines as Topic | 1 | 2014 | 159 | 0.100 |
Why?
|
| Sarcoma, Ewing | 1 | 1993 | 13 | 0.100 |
Why?
|
| Information Storage and Retrieval | 2 | 2013 | 60 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 2329 | 0.090 |
Why?
|
| Infant | 6 | 2025 | 1720 | 0.090 |
Why?
|
| Mathematics | 1 | 2012 | 34 | 0.090 |
Why?
|
| Papanicolaou Test | 2 | 2009 | 46 | 0.090 |
Why?
|
| Community Participation | 2 | 2012 | 48 | 0.090 |
Why?
|
| Vaginal Smears | 2 | 2009 | 59 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1635 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 319 | 0.090 |
Why?
|
| Physical Education and Training | 1 | 2012 | 29 | 0.090 |
Why?
|
| Meaningful Use | 1 | 2012 | 9 | 0.090 |
Why?
|
| Fluorine Radioisotopes | 1 | 1992 | 8 | 0.090 |
Why?
|
| Corpus Striatum | 1 | 2013 | 99 | 0.090 |
Why?
|
| Tomography, Emission-Computed | 1 | 1992 | 43 | 0.090 |
Why?
|
| Deoxyglucose | 1 | 1992 | 32 | 0.090 |
Why?
|
| Financing, Organized | 1 | 2012 | 16 | 0.090 |
Why?
|
| Coffee | 1 | 1992 | 18 | 0.090 |
Why?
|
| Abdominal Neoplasms | 1 | 1992 | 22 | 0.090 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 294 | 0.090 |
Why?
|
| Neuronavigation | 1 | 2011 | 13 | 0.090 |
Why?
|
| Community Networks | 2 | 2008 | 28 | 0.090 |
Why?
|
| Health Literacy | 1 | 2012 | 95 | 0.090 |
Why?
|
| Population Surveillance | 2 | 2010 | 210 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 1 | 1993 | 253 | 0.090 |
Why?
|
| Animals, Genetically Modified | 3 | 2018 | 312 | 0.090 |
Why?
|
| Risk-Taking | 4 | 2016 | 159 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2018 | 714 | 0.080 |
Why?
|
| Efficiency, Organizational | 1 | 2012 | 98 | 0.080 |
Why?
|
| Preventive Medicine | 1 | 1991 | 25 | 0.080 |
Why?
|
| Fasciitis | 1 | 1991 | 5 | 0.080 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2011 | 73 | 0.080 |
Why?
|
| Health Services Research | 1 | 2012 | 265 | 0.080 |
Why?
|
| Thoracic Arteries | 1 | 1990 | 3 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 526 | 0.080 |
Why?
|
| Activating Transcription Factors | 1 | 2010 | 11 | 0.080 |
Why?
|
| Mammary Arteries | 1 | 1990 | 11 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 1995 | 475 | 0.080 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 45 | 0.080 |
Why?
|
| Mediastinum | 1 | 1990 | 28 | 0.080 |
Why?
|
| Immobilization | 1 | 2010 | 14 | 0.080 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2010 | 76 | 0.080 |
Why?
|
| Behavioral Risk Factor Surveillance System | 2 | 2008 | 45 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2013 | 357 | 0.080 |
Why?
|
| Curriculum | 2 | 2017 | 609 | 0.080 |
Why?
|
| Communications Media | 1 | 2009 | 4 | 0.080 |
Why?
|
| Breast | 1 | 2012 | 194 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 104 | 0.080 |
Why?
|
| Tumor Burden | 1 | 2010 | 77 | 0.080 |
Why?
|
| Arm | 1 | 1990 | 45 | 0.080 |
Why?
|
| Computer Communication Networks | 2 | 2008 | 12 | 0.080 |
Why?
|
| Patient Positioning | 1 | 2010 | 52 | 0.080 |
Why?
|
| Aneurysm | 1 | 1990 | 58 | 0.080 |
Why?
|
| Human papillomavirus 6 | 1 | 2009 | 4 | 0.080 |
Why?
|
| Condylomata Acuminata | 1 | 2009 | 9 | 0.070 |
Why?
|
| Brain | 3 | 2015 | 1672 | 0.070 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2009 | 20 | 0.070 |
Why?
|
| Histological Techniques | 1 | 1989 | 19 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 2496 | 0.070 |
Why?
|
| Genital Neoplasms, Female | 1 | 2009 | 18 | 0.070 |
Why?
|
| Program Evaluation | 2 | 2008 | 501 | 0.070 |
Why?
|
| Environmental Health | 1 | 1989 | 14 | 0.070 |
Why?
|
| Regression Analysis | 2 | 2011 | 498 | 0.070 |
Why?
|
| Administrative Personnel | 1 | 1989 | 30 | 0.070 |
Why?
|
| Linear Models | 2 | 2009 | 405 | 0.070 |
Why?
|
| Retrospective Studies | 8 | 2014 | 6953 | 0.070 |
Why?
|
| Sex Distribution | 4 | 2011 | 252 | 0.070 |
Why?
|
| Animals | 9 | 2021 | 21489 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2009 | 606 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 413 | 0.070 |
Why?
|
| Insurance, Health | 1 | 2010 | 153 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 333 | 0.070 |
Why?
|
| Mental Processes | 1 | 2008 | 18 | 0.070 |
Why?
|
| Diagnostic Errors | 1 | 1989 | 106 | 0.070 |
Why?
|
| Puerto Rico | 3 | 2014 | 143 | 0.070 |
Why?
|
| Sick Role | 1 | 2007 | 20 | 0.060 |
Why?
|
| Friends | 1 | 2007 | 28 | 0.060 |
Why?
|
| Ganglionic Stimulants | 1 | 2007 | 6 | 0.060 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2007 | 8 | 0.060 |
Why?
|
| Cotinine | 1 | 2007 | 20 | 0.060 |
Why?
|
| Algorithms | 2 | 2010 | 1060 | 0.060 |
Why?
|
| Genome, Viral | 2 | 2018 | 145 | 0.060 |
Why?
|
| Cosmetics | 1 | 2006 | 17 | 0.060 |
Why?
|
| Women's Health | 1 | 2009 | 376 | 0.060 |
Why?
|
| Cosmetic Techniques | 1 | 2006 | 13 | 0.060 |
Why?
|
| Testicular Neoplasms | 1 | 2006 | 35 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 799 | 0.060 |
Why?
|
| Attention | 1 | 2008 | 154 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 466 | 0.060 |
Why?
|
| Skin Pigmentation | 1 | 2006 | 34 | 0.060 |
Why?
|
| Depression | 2 | 2016 | 910 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2019 | 1583 | 0.060 |
Why?
|
| Physician's Role | 1 | 2007 | 122 | 0.060 |
Why?
|
| Overweight | 1 | 2008 | 254 | 0.060 |
Why?
|
| Sheep, Domestic | 2 | 2018 | 13 | 0.060 |
Why?
|
| Social Perception | 1 | 2006 | 44 | 0.060 |
Why?
|
| Nicotine | 1 | 2007 | 118 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2006 | 144 | 0.060 |
Why?
|
| Confidence Intervals | 3 | 2011 | 237 | 0.060 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2007 | 126 | 0.060 |
Why?
|
| Neoplasm Grading | 2 | 2015 | 101 | 0.050 |
Why?
|
| Intention | 1 | 2025 | 74 | 0.050 |
Why?
|
| Respiration Disorders | 1 | 2005 | 26 | 0.050 |
Why?
|
| Consensus | 2 | 2019 | 174 | 0.050 |
Why?
|
| Marijuana Smoking | 1 | 2005 | 20 | 0.050 |
Why?
|
| Bone and Bones | 3 | 1992 | 152 | 0.050 |
Why?
|
| Food | 2 | 2015 | 76 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 1 | 2004 | 105 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2024 | 1029 | 0.050 |
Why?
|
| State Government | 2 | 2014 | 32 | 0.050 |
Why?
|
| Food, Fortified | 1 | 2024 | 19 | 0.050 |
Why?
|
| World Health Organization | 1 | 2024 | 36 | 0.050 |
Why?
|
| Incidence | 2 | 2024 | 1432 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2025 | 5830 | 0.050 |
Why?
|
| Religion | 1 | 2004 | 35 | 0.050 |
Why?
|
| Fear | 1 | 2004 | 71 | 0.050 |
Why?
|
| Safety | 2 | 1997 | 142 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2025 | 325 | 0.050 |
Why?
|
| Qualitative Research | 3 | 2013 | 763 | 0.050 |
Why?
|
| Commerce | 1 | 2022 | 58 | 0.040 |
Why?
|
| Drug Administration Routes | 1 | 2021 | 22 | 0.040 |
Why?
|
| Neuroticism | 1 | 2021 | 3 | 0.040 |
Why?
|
| Suicide | 1 | 2004 | 147 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2019 | 2649 | 0.040 |
Why?
|
| Policy | 1 | 2022 | 55 | 0.040 |
Why?
|
| Arthritis, Infectious | 2 | 1991 | 20 | 0.040 |
Why?
|
| Hazardous Substances | 1 | 2001 | 16 | 0.040 |
Why?
|
| Humerus | 2 | 1992 | 11 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2022 | 104 | 0.040 |
Why?
|
| Radius | 2 | 1992 | 20 | 0.040 |
Why?
|
| Civil Defense | 1 | 2001 | 16 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2019 | 3339 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1991 | 129 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2001 | 110 | 0.040 |
Why?
|
| Culture | 2 | 2013 | 82 | 0.040 |
Why?
|
| Communicable Diseases | 1 | 2001 | 86 | 0.040 |
Why?
|
| Fibrous Dysplasia of Bone | 2 | 1990 | 5 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 1172 | 0.040 |
Why?
|
| Health Policy | 1 | 2022 | 191 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2010 | 426 | 0.040 |
Why?
|
| Mutation | 2 | 2019 | 2674 | 0.040 |
Why?
|
| Patella | 2 | 1990 | 13 | 0.040 |
Why?
|
| Mice | 4 | 2019 | 11185 | 0.040 |
Why?
|
| Biopsy | 3 | 2015 | 463 | 0.040 |
Why?
|
| Residence Characteristics | 2 | 2012 | 230 | 0.040 |
Why?
|
| Cell Phone | 1 | 2019 | 42 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2019 | 180 | 0.030 |
Why?
|
| Wool | 1 | 2018 | 5 | 0.030 |
Why?
|
| Electrolytes | 1 | 2018 | 26 | 0.030 |
Why?
|
| Internal Capsule | 1 | 2018 | 11 | 0.030 |
Why?
|
| Mobile Applications | 1 | 2020 | 142 | 0.030 |
Why?
|
| Serogroup | 1 | 2018 | 35 | 0.030 |
Why?
|
| Injections | 1 | 2018 | 84 | 0.030 |
Why?
|
| Demography | 2 | 2010 | 178 | 0.030 |
Why?
|
| Immunoassay | 1 | 2018 | 71 | 0.030 |
Why?
|
| Capacity Building | 1 | 2017 | 23 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2001 | 264 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2009 | 1146 | 0.030 |
Why?
|
| Radionuclide Imaging | 2 | 2015 | 129 | 0.030 |
Why?
|
| Dietary Sucrose | 1 | 2017 | 24 | 0.030 |
Why?
|
| Industry | 1 | 1997 | 59 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 372 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2016 | 92 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2017 | 122 | 0.030 |
Why?
|
| Patient Preference | 1 | 2016 | 87 | 0.030 |
Why?
|
| Semantics | 1 | 2016 | 58 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2010 | 1573 | 0.030 |
Why?
|
| Joint Diseases | 1 | 1995 | 22 | 0.030 |
Why?
|
| Kidney | 1 | 2018 | 460 | 0.030 |
Why?
|
| Lipoma | 2 | 1995 | 17 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2017 | 202 | 0.030 |
Why?
|
| Pituitary Neoplasms | 1 | 2015 | 21 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2015 | 67 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2019 | 447 | 0.030 |
Why?
|
| Occupational Health | 1 | 1997 | 195 | 0.030 |
Why?
|
| Aerospace Medicine | 1 | 1995 | 12 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2016 | 169 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 593 | 0.030 |
Why?
|
| Microglia | 1 | 2018 | 254 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 401 | 0.030 |
Why?
|
| Sampling Studies | 2 | 1991 | 65 | 0.030 |
Why?
|
| Shoulder | 2 | 1992 | 29 | 0.030 |
Why?
|
| Lymphedema | 1 | 2014 | 7 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 223 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2014 | 47 | 0.030 |
Why?
|
| Diagnostic Imaging | 2 | 1994 | 274 | 0.030 |
Why?
|
| Postmenopause | 1 | 2015 | 241 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2015 | 77 | 0.030 |
Why?
|
| Child Behavior | 1 | 2014 | 67 | 0.030 |
Why?
|
| Hotlines | 1 | 2013 | 21 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2014 | 147 | 0.030 |
Why?
|
| Gender Identity | 1 | 2014 | 69 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2015 | 147 | 0.020 |
Why?
|
| Computer Security | 1 | 2013 | 16 | 0.020 |
Why?
|
| Quality Control | 1 | 1993 | 79 | 0.020 |
Why?
|
| Fatigue | 1 | 2014 | 114 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 204 | 0.020 |
Why?
|
| Internal-External Control | 1 | 2013 | 34 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 2014 | 102 | 0.020 |
Why?
|
| Chondroblastoma | 2 | 1993 | 2 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 171 | 0.020 |
Why?
|
| Extremities | 2 | 1991 | 63 | 0.020 |
Why?
|
| Liver | 1 | 2018 | 875 | 0.020 |
Why?
|
| Geographic Information Systems | 1 | 2013 | 22 | 0.020 |
Why?
|
| Managed Care Programs | 1 | 1993 | 86 | 0.020 |
Why?
|
| Certification | 1 | 1993 | 58 | 0.020 |
Why?
|
| Stereotaxic Techniques | 1 | 2013 | 30 | 0.020 |
Why?
|
| Cholesterol | 1 | 2014 | 262 | 0.020 |
Why?
|
| Body Weight | 1 | 2014 | 377 | 0.020 |
Why?
|
| Canada | 1 | 2013 | 157 | 0.020 |
Why?
|
| Myxoma | 2 | 1989 | 14 | 0.020 |
Why?
|
| Software | 1 | 2016 | 401 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2014 | 195 | 0.020 |
Why?
|
| Family Characteristics | 1 | 2012 | 46 | 0.020 |
Why?
|
| Metacarpus | 1 | 1992 | 1 | 0.020 |
Why?
|
| Metatarsus | 1 | 1992 | 1 | 0.020 |
Why?
|
| Triglycerides | 1 | 2014 | 249 | 0.020 |
Why?
|
| Ulna | 1 | 1992 | 5 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1117 | 0.020 |
Why?
|
| Fibula | 1 | 1992 | 10 | 0.020 |
Why?
|
| Geography | 1 | 2012 | 37 | 0.020 |
Why?
|
| Diagnostic Techniques, Surgical | 1 | 1992 | 1 | 0.020 |
Why?
|
| Utah | 1 | 1992 | 6 | 0.020 |
Why?
|
| Sarcoma, Synovial | 1 | 1992 | 6 | 0.020 |
Why?
|
| Fingers | 1 | 1992 | 49 | 0.020 |
Why?
|
| Tea | 1 | 1992 | 32 | 0.020 |
Why?
|
| Seat Belts | 1 | 1991 | 9 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2011 | 69 | 0.020 |
Why?
|
| Sunlight | 1 | 1991 | 28 | 0.020 |
Why?
|
| Pelvic Bones | 1 | 1991 | 17 | 0.020 |
Why?
|
| Preconception Care | 1 | 1991 | 23 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1992 | 102 | 0.020 |
Why?
|
| Bone Cysts | 2 | 1989 | 6 | 0.020 |
Why?
|
| Necrosis | 1 | 1992 | 148 | 0.020 |
Why?
|
| Hip Joint | 1 | 1991 | 37 | 0.020 |
Why?
|
| Energy Intake | 1 | 2012 | 173 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1992 | 67 | 0.020 |
Why?
|
| Forearm | 1 | 1991 | 23 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2011 | 99 | 0.020 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 1991 | 8 | 0.020 |
Why?
|
| Gadolinium | 1 | 2011 | 111 | 0.020 |
Why?
|
| Rectum | 1 | 1991 | 97 | 0.020 |
Why?
|
| Carmustine | 1 | 2010 | 11 | 0.020 |
Why?
|
| Wrist Joint | 1 | 1991 | 26 | 0.020 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1991 | 95 | 0.020 |
Why?
|
| Spinal Neoplasms | 1 | 1990 | 16 | 0.020 |
Why?
|
| Actigraphy | 1 | 2011 | 51 | 0.020 |
Why?
|
| Spheroids, Cellular | 1 | 2010 | 28 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 165 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2010 | 14 | 0.020 |
Why?
|
| Insulin | 1 | 2014 | 696 | 0.020 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2010 | 24 | 0.020 |
Why?
|
| Niacinamide | 1 | 2010 | 33 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2010 | 32 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 1991 | 138 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2010 | 287 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2010 | 218 | 0.020 |
Why?
|
| Dipeptides | 1 | 2010 | 69 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 302 | 0.020 |
Why?
|
| Osteitis Deformans | 1 | 1990 | 2 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 241 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 167 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 413 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2010 | 3168 | 0.020 |
Why?
|
| Social Change | 1 | 2009 | 13 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 203 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2010 | 110 | 0.020 |
Why?
|
| Online Systems | 1 | 2009 | 20 | 0.020 |
Why?
|
| Blogging | 1 | 2009 | 11 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 1990 | 99 | 0.020 |
Why?
|
| Nutrition Assessment | 1 | 2009 | 28 | 0.020 |
Why?
|
| Occult Blood | 1 | 2009 | 19 | 0.020 |
Why?
|
| Exons | 1 | 2010 | 208 | 0.020 |
Why?
|
| Bone Diseases | 1 | 1990 | 25 | 0.020 |
Why?
|
| Electronic Mail | 1 | 2010 | 46 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2017 | 802 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 195 | 0.020 |
Why?
|
| Pyridines | 1 | 2010 | 120 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 741 | 0.020 |
Why?
|
| Cell Division | 1 | 2010 | 451 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2010 | 86 | 0.020 |
Why?
|
| Telephone | 1 | 2009 | 123 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2009 | 97 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 289 | 0.020 |
Why?
|
| Health Services | 1 | 2009 | 80 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 1992 | 309 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 542 | 0.020 |
Why?
|
| Institutional Management Teams | 1 | 2008 | 3 | 0.020 |
Why?
|
| Time Management | 1 | 2008 | 8 | 0.020 |
Why?
|
| Empirical Research | 1 | 2008 | 15 | 0.020 |
Why?
|
| Creativity | 1 | 2008 | 14 | 0.020 |
Why?
|
| Muscles | 1 | 1989 | 179 | 0.020 |
Why?
|
| Income | 1 | 2009 | 169 | 0.020 |
Why?
|
| Censuses | 1 | 2008 | 18 | 0.020 |
Why?
|
| Social Class | 1 | 2009 | 137 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2008 | 102 | 0.020 |
Why?
|
| Individuality | 1 | 2008 | 24 | 0.020 |
Why?
|
| SEER Program | 1 | 2008 | 75 | 0.020 |
Why?
|
| Organizational Innovation | 1 | 2008 | 85 | 0.020 |
Why?
|
| Attitude | 1 | 2008 | 102 | 0.020 |
Why?
|
| Mental Recall | 1 | 2008 | 95 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2008 | 137 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2009 | 370 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 2007 | 29 | 0.020 |
Why?
|
| Self-Help Groups | 1 | 2007 | 37 | 0.020 |
Why?
|
| Mammography | 1 | 2009 | 296 | 0.020 |
Why?
|
| Beauty Culture | 1 | 2006 | 16 | 0.020 |
Why?
|
| Protective Clothing | 1 | 2006 | 29 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 464 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 647 | 0.020 |
Why?
|
| Radiation Protection | 1 | 2006 | 27 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 296 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 1792 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 645 | 0.010 |
Why?
|
| Research Design | 1 | 2008 | 590 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2007 | 279 | 0.010 |
Why?
|
| Respiratory Sounds | 1 | 2005 | 21 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 1100 | 0.010 |
Why?
|
| Spirometry | 1 | 2005 | 114 | 0.010 |
Why?
|
| Dyspnea | 1 | 2005 | 120 | 0.010 |
Why?
|
| Massachusetts | 1 | 2010 | 2158 | 0.010 |
Why?
|
| Cough | 1 | 2005 | 183 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 3504 | 0.010 |
Why?
|
| Hospitalization | 1 | 2010 | 1403 | 0.010 |
Why?
|
| Liposarcoma | 2 | 1991 | 8 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1997 | 106 | 0.010 |
Why?
|
| Synovial Cyst | 1 | 1995 | 1 | 0.010 |
Why?
|
| Occupational Diseases | 1 | 1997 | 266 | 0.010 |
Why?
|
| Cartilage, Articular | 1 | 1995 | 79 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1995 | 199 | 0.010 |
Why?
|
| Image Enhancement | 1 | 1995 | 196 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1995 | 553 | 0.010 |
Why?
|
| Osteochondroma | 1 | 1993 | 3 | 0.010 |
Why?
|
| Chondroma | 1 | 1993 | 3 | 0.010 |
Why?
|
| Diatrizoate Meglumine | 1 | 1991 | 6 | 0.010 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 1991 | 16 | 0.010 |
Why?
|
| Enema | 1 | 1991 | 14 | 0.010 |
Why?
|
| Medical History Taking | 1 | 1991 | 65 | 0.010 |
Why?
|
| Back Pain | 1 | 1990 | 49 | 0.000 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1991 | 84 | 0.000 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 1990 | 2 | 0.000 |
Why?
|
| Lipomatosis | 1 | 1990 | 7 | 0.000 |
Why?
|
| Alkaline Phosphatase | 1 | 1990 | 46 | 0.000 |
Why?
|
| Neurofibroma | 1 | 1989 | 3 | 0.000 |
Why?
|
| Synovitis, Pigmented Villonodular | 1 | 1989 | 3 | 0.000 |
Why?
|
| Epidermal Cyst | 1 | 1989 | 11 | 0.000 |
Why?
|
| Angiography | 1 | 1990 | 154 | 0.000 |
Why?
|
| Nervous System Diseases | 1 | 1990 | 109 | 0.000 |
Why?
|
| Abscess | 1 | 1989 | 79 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1989 | 131 | 0.000 |
Why?
|